Discovery and characterization of new original blocking antibodies targeting the CD73 immune checkpoint for cancer immunotherapy

被引:4
|
作者
Paoli, Marc Giraudon
Augier, Severine
Blemont, Marilyne Royannez
Rodriguez, Celine
Blanc, Helene Rispaud
Chanteux, Stephanie
Gourdin, Nicolas
Gauthier, Laurent
Caux, Christine Menetrier
Morel, Yannis
Caux, Christophe
Paturel, Carine
Perrot, Ivan
机构
关键词
D O I
10.1158/1538-7445.AM2016-2344
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2344
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Preclinical development of humanized CD39 and CD73 blocking antibodies targeting the ATP/adenosine immune checkpoint pathway for cancer immunotherapy
    Perrot, Ivan
    Paoli, Marc Giraudon
    Augier, Severine
    Blemont, Marilyne Royannez
    Gaudin, Marion
    Bosco, Frederic
    Courtois, Rachel
    Delahaye, Stephane
    Jecko, Diana
    Gourdin, Nicolas
    Agu, Maryline Salin
    Perrier, Cyril
    Ricaut, Paul
    Docquier, Aurelie
    Chanteux, Stephanie
    Rossi, Benjamin
    Represa, Agnes
    Denis, Caroline
    Remark, Romain
    Bonnafous, Cecile
    Gauthier, Laurent
    Morel, Ariane
    Bonnefoy, Nathalie
    Bastid, Jeremy
    Morel, Yannis
    Paturel, Carine
    CANCER RESEARCH, 2018, 78 (13)
  • [2] CD73: an emerging checkpoint for cancer immunotherapy
    Chen, Siqi
    Wainwright, Derek A.
    Wu, Jennifer D.
    Wan, Yong
    Matei, Daniela E.
    Zhang, Yi
    Zhang, Bin
    IMMUNOTHERAPY, 2019, 11 (11) : 983 - 997
  • [3] Targeting CD73 to augment cancer immunotherapy
    Roh, Meejeon
    Wainwright, Derek A.
    Wu, Jennifer D.
    Wan, Yong
    Zhang, Bin
    CURRENT OPINION IN PHARMACOLOGY, 2020, 53 : 66 - 76
  • [4] CD73: a new immune checkpoint for leukemia treatment
    Gao, Huan
    Zhang, Tingting
    Li, Ke
    Li, Xia
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [5] Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
    Perrot, Ivan
    Michaud, Henri-Alexandre
    Giraudon-Paoli, Marc
    Augier, Severine
    Docquier, Aurelie
    Gros, Laurent
    Courtois, Rachel
    Dejou, Cecile
    Jecko, Diana
    Becquart, Ondine
    Rispaud-Blanc, Helene
    Gauthier, Laurent
    Rossi, Benjamin
    Chanteux, Stephanie
    Gourdin, Nicolas
    Amigues, Beatrice
    Roussel, Alain
    Bensussan, Armand
    Eliaou, Jean-Francois
    Bastid, Jeremy
    Romagne, Francois
    Morel, Yannis
    Narni-Mancinelli, Emilie
    Vivier, Eric
    Paturel, Carine
    Bonnefoy, Nathalie
    CELL REPORTS, 2019, 27 (08): : 2411 - +
  • [6] IPH5301, a CD73 blocking antibody targeting the adenosine immunosuppressive pathway for cancer immunotherapy
    Perrot, Ivan
    Denis, Caroline
    Giraudon-Paoli, Marc
    Augier, Severine
    Courtois, Rachel
    Jecko, Diana
    Breso, Violette
    Arnoux, Thomas
    Gourdin, Nicolas
    Remark, Romain
    Bonnafous, Cecile
    Morel, Ariane
    Vivier, Eric
    Morel, Yannis
    Andre, Pascale
    Paturel, Carine
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [7] Targeting CD73 to improves tumor immunotherapy
    Zhang, Bin
    Jin, Dachuan
    Fan, Jie
    Wang, Long
    Thompson, Linda
    Liu, Aijie
    Daniel, Ben
    Shin, Tahiro
    Curiel, Tyler
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [8] CD73 as a target in cancer immunotherapy
    Smyth, Mark J.
    Beayis, Paul
    Darcy, Phil K.
    Loi, Sherene
    Stagg, John
    CANCER RESEARCH, 2012, 72
  • [9] Identification of CD73 and A2AR/CD73 small molecule inhibitors for cancer immunotherapy as single agents or in combination with Immune-checkpoint therapies
    Fons, Pierre
    Bell, Andrew
    Esquerre, Michael
    Versluys, Stephanie
    Bertrand, Florie
    Schreyer, Adrian
    Hopkins-Navratilova, Iva
    Hernani, Leonardo-Silvestre
    Bergeaud, Celia
    Poussereau-Pomie, Celine
    Marchand, Ghislaine
    Robinson, Sean
    Culurgioni, Simone
    Cox, Richard
    Besnard, Jeremy
    Payne, Andrew
    Ray, Peter
    Pelissier, Emilie
    Paillasse, Michael
    Lisztwan, Joanna
    Johnstone, Craig
    Whittaker, Mark
    Hopkins, Andrew
    CANCER RESEARCH, 2019, 79 (13)
  • [10] CD73 Is a Critical Immune Checkpoint in a Molecular Subtype of Pancreatic Cancer
    DelGiorno, Kathleen
    CANCER RESEARCH, 2023, 83 (07) : 977 - 978